Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Jean-Paul Achkar, MD, is a Staff Physician in the Department of Gastroenterology of the Digestive Disease Center, located on the main campus of Cleveland Clinic. From 2002 to 2007, he served as Director of the Cleveland Clinic Gastroenterology Fellowship Program. He is certified in gastroenterology by the National Board of Examiners, and his specialty interests include Crohn's disease and ulcerative colitis.
Dr. Achkar received his medical degree from Case Western Reserve University School of Medicine. He also conducted his internship and residency in internal medicine at University Hospitals of Cleveland/Case Western Reserve University, where he served as Chief Resident in Internal Medicine. He then went on to conduct his fellowship in gastroenterology and hepatology at the University of Pittsburgh Medical Center, where he was Chief Fellow.
He is principal or co-investigator in several research trials that have been published in leading peer-reviewed journals. He has also contributed chapters to several medical textbooks in his field. He is the recipient of research awards from the National Institutes of Health (NIH), Cleveland Clinic, GlaxoSmithKline Institute for Digestive Health and the American College of Gastroenterology.
Dr. Achkar has also received the Physician of the Year Award from the Gastroenterology Department of Cleveland Clinic, the Crohn’s and Colitis Foundation of America Premier Physician Award, two Senior Fellow Teaching Awards, and the American College of Gastroenterology Governors Award for Best Scientific Paper. He is a member of the American College of Gastroenterology, the American Gastroenterological Association, and the Crohn’s and Colitis Foundation of America.
National Institutes of Health K23 Grant Award for Genetic Studies in Crohn’s Disease
Crohn's Disease, IBD including ulcerative colitis and Crohn's, inflammatory bowel disease, ulcerative colitis
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 12/20/2015, Dr. Achkar has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.